When a retinal detachment isn’t a retinal detachment

Publication
Article
Optometry Times JournalOctober digital edition 2020
Volume 12
Issue 10

A wrinkled retina suggests detachment, but additional clinical findings prove otherwise

Figure 1. Color fundus photography of the right fundus. Note the wrinkled appearance to the retina inferior to the macula.

A 49-year-old patient who presented with a wrinkled retina shows how tricky retinal detachment can be to diagnose. Visual fields and clinical correlation were helpful in making the final diagnosis.

The patient whose fundus image is shown in Figure 1 had been followed for refractive care as well as retinoschisis. At the present visit at age 49, he attended for periodic evaluation. The patient did not report new or different visual or ocular symptoms. The anterior segment and interocular pressure (IOP) readings were withing the statistically normal range.

Case report

The fundus appearance is one of a wrinkled retina encroaching from inferiorly which was the site of previously diagnosed retinoschisis in the right eye. Visual acuity was correctable to 20/20 in each eye with moderate myopic refractive correction. The left eye showed no involvement of retinoschisis.

At this visit, visual field testing was ordered to assess functional impairment. The visual field of the right eye is shown in Figure 2. The uninvolved left fundus image and visual field are not shown.

The characterization of retinoschisis (senile, degenerative, or acquired) has been presented clinically and histologically decades ago,1,2 and more recently using optical coherence tomography (OCT).3 A common confusion of bullous retinoschisis is bullous retinal detachment as has been recently reported.4

Figure 2. Central visual field of the right eye demonstrating absolute superior depression corresponding to the fundus appearance.

More from the October 2020 issue: Protect patients’ eyes by encouraging a three-step ocular wellness regimen

Clinical features

The wrinkled retina in the present case may suggest retinal detachment, but several clinical features argue against this diagnosis.

First, the patient’s history is consistent with retinoschisis.

Second, the visual field result in the right eye shows an absolute depression while a fresh retinal detachment would more likely show a relative defect.

Third, the patient was not symptomatic for retinal detachment, nor was vitreous detachment or hemorrhage observed.

A recent report of a large series of acute posterior vitreous detachment both of the later clinical observations were identified as risk factors for retinal detachment.5 A simple clinical diagnostic that I have used is based on the anatomy of retinoschisis, a split between the inner and outer retinal layers, is to shine a directed beam of light at the area in question and note the response of the patient. The absolute scotoma of retinoschisis (no perception of the light) may be the first step in confirming retinoschisis.

Further characterization can be obtained from optical coherence tomography (OCT). In my experience, this is a difficult data point to generate. It requires wide pupillary dilation, a cooperative patient, as well as a patient and skilled technician. However, in questionable cases this may be a valuable study to conduct which may spare the patient in a primary-care scenario a consultation with a retina specialist. Kampetter and Jonas offer excellent clinical and OCT correlation along with histological examples for the interested reader.5 Widefield imaging may be useful in the clinical distinction between retinal detachment and retinoschisis, too.4

Treatment

Argon laser photocoagulation to collapse the cavity is futile, but application of a barrier posterior to the margin of the lesion has been suggested as prophylactically beneficial.6 Management of retinoschisis is generally observation until the macula is threatened or retinal detachment secondary to retinal breaks occurs. A complete guide to management can be found at the American Academy of Ophthalmology (AAO) Preferred Practice pattern website.7

Interestingly, this patient was reminded of the symptoms and risks of retinal detachment and asked to return if any appeared or in 1 year’s time. He returned within 3 months symptomatic for posterior vitreous/retinal detachment. A peripheral retinal tear was observed, and the patient underwent prophylactic argon-laser photocoagulation.

More by Dr. Semes: The evolving standard of care in AMD

References

1. Yassur Y, Feldberg R, Axer-Siegel R, Silverston B, Manor R, Ben-Sira I. Argon laser treatment of senile retinoschisis. Br J Ophthalmol. 1983;67(6):381-384.

2. Straatsma BR, Foss RY. Typical and reticular degenerative retinoschisis. Am J Ophthalmol. 1973;75(4):551-575.

3. Kamppeter BA, Jonas JB. Optical coherence tomography of a peripheral retinal schisis with an outer retinal layer break. Acta Ophthalmol Scand. 2004;82(5):574-575.

4. Handa S, Arora A, Kumar N, Bansal R. Bullous retinoschisis. Indian J Ophthalmol. 2019 Oct; 67(10):1734.

5. Uhr JH, Obeid A, Wibbelsman TD, et al. Delayed Retinal Breaks and Detachments after Acute Posterior Vitreous Detachment. Ophthalmology. 2020;127(4):516-522.

6. Yassur Y, Feldberg R, Axer-Siegel R, Silverston B, Manor R, Ben-Sira I. Argon laser treatment of senile retinoschisis. Br J Ophthalmol. 1983;67(6):381-384.

7. American Academy of Ophthalmology. Senile Retinoschisis. Available at: https://eyewiki.org/Senile_Retinoschisis. Updated May 29, 2020. Accessed 7/15/20

Recent Videos
Dr Carolyn Majcher chats about GA and posterior uveitis at AAOpt 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Ferrucci summarizes his Vision Expo West presentations and shares clinical pearls for managing retinal cases.
Mohammad Rafieetary, OD, FAAO
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
© 2024 MJH Life Sciences

All rights reserved.